How to buy Edwards Lifesciences shares

Edwards Lifesciences shares have increased 0.19% from yesterday's closing price ($80.92). Learn how to easily invest in Edwards Lifesciences shares in the UK.

Edwards Lifesciences Corp (EW) is a publicly traded medical devices business based in the US. In the week up to 19 March Edwards Lifesciences shares surged 8.61% to a closing position of $80.74. However, over the last 12 months, Edwards Lifesciences's share price has fallen by 29.11% from $114.13. Edwards Lifesciences is listed on the NYSE and employs 17,300 staff. All prices are listed in US Dollars.

How to buy shares in Edwards Lifesciences

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: EW in this case.
  5. Research Edwards Lifesciences shares. The platform should provide the latest information available.
  6. Buy your Edwards Lifesciences shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our top picks for where to buy Edwards Lifesciences shares:

Best for

Beginner investments

IG Share Dealing image

Fees for buying 10x Edwards Lifesciences shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Customer rating Platform fee Min. initial deposit Trading fee estimate
Freetrade logo ★★★★★ £0 £1 £2.95
£659.38 total
Capital at risk
eToro Free Stocks logo ★★★★★ £0 $50 £3.28
£659.70 total
Capital at risk
IG Share Dealing logo ★★★★★ £0 £250 £11.44
£667.86 total
Capital at risk
CMC Invest logo Not yet rated £0 No minimum £3.28
£659.70 total
Capital at risk
Fineco logo ★★★★★ £0 No minimum £6.56
£662.99 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo ★★★★★ £0 £1 £18.51
£674.94 total
Capital at risk
Degiro Share Dealing logo ★★★★★ £0 £0.01 £0.66
£657.08 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in Edwards Lifesciences

Is it a good time to buy Edwards Lifesciences stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks

Invest in Edwards Lifesciences shares

  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Edwards Lifesciences under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Edwards Lifesciences P/E ratio, PEG ratio and EBITDA

Edwards Lifesciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 32x. In other words, Edwards Lifesciences shares trade at around 32x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Edwards Lifesciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0653. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Edwards Lifesciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.9 billion (£1.6 billion).

The EBITDA is a measure of a Edwards Lifesciences's overall financial performance and is widely used to measure a its profitability.

What's Edwards Lifesciences's ESG track record?

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences.

Overall Edwards Lifesciences ESG score

Edwards Lifesciences's total ESG risk: 21.68

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences's overall score of 21.68 (as at 01/01/2019) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Edwards Lifesciences's environmental score: 4.78/100

Edwards Lifesciences's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Edwards Lifesciences's social score: 13.43/100

Edwards Lifesciences's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Edwards Lifesciences's governance score: 10.96/100

Edwards Lifesciences's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Edwards Lifesciences's controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Edwards Lifesciences scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences has, for the most part, managed to keep its nose clean.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

  • How to buy Blue Water Vaccines shares

    Ever wondered how to buy shares in Blue Water Vaccines? We explain how and compare a range of providers that can give you access to many brands, including Blue Water Vaccines.

  • How to buy Veru shares

    Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.

  • How to buy C4 Therapeutics shares

    Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.

  • How to buy Clever Leaves shares

    Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.

  • How to buy NeuroSense Therapeutics shares

    Ever wondered how to buy shares in NeuroSense Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including NeuroSense Therapeutics.

  • Mental health stocks: Popular mental health companies to invest in

    Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.

  • Invest in pharmaceutical stocks

    Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.

  • How to buy Bone Biologics shares

    Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.

  • How to buy Adagio Therapeutics shares

    Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.

  • How to buy Bolt Biotherapeutics shares

    Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site